Category: ConMed Corp.
Calhoun Vision replaces Verne Sharma in the corner office with former Bausch & Lomb executive Rick Heinick.
There was a significant amount of turnover this year in the corner offices of medical device companies, including exits by some of medtech's biggest names.
There was a revolving door on medtech's corner office this year, with more than 35 CEOs leaving their positions through planned transitions, retirement or termination, according to a MassDevice.com analysis.
Wound care giant Acelity says it snared Smith & Nephew's orthopedic reconstruction president Guarav Agarwal, for its newly created president of business & innovation role.
Here's a look at some of the top regulatory stories for medical device companies this week: FDA gives the green light to Stimwave's mini spinal cord stimulator; HeartFlow wins FDA OK for non-invasive FFR system; FDA warns AngioDynamics subsidiary Navilyst on hairs in PICC packaging; Philips defib updates spur ConMed electrode recall; FDA approves J&J spinal device for rare pediatric syndrome
The FDA assigns Class I recall status to several lines of ConMed's defibrillator electrodes because they won't function with a number of updated devices made by Philips.
ConMed makes ex-Stryker CEO Curt Hartman its permanent CEO after a 3-month interim period.
, Bovie Medical Corp.
, ConMed Corp.
, EnteroMedics Inc.
, Perseon (formerly BSD Medical)
, Profound Medical Inc.
, RainDance Technologies Inc.
Here's a look at some of the top Wall Street stories for medical device companies this week: Will Medtronic follow Walgreen and abandon inversion in Covidien deal?; ElectroCore seeks commercial partners for non-invasive headache tech; Allergan-Valeant update: SEC launches Ackman probe, Allergan pays up to $588M for Liris bladder drug, Ackman dangles IPO; Activist investor battles on over ConMed as shareholders vote approaches; Medtronic's Q1 earnings beat The Street on modest sales bump